ACC.21 Congress (American College of Cardiology 2021 Congress) (Nā wikiō)

E kiʻi ʻoe i ka link VIA LIFETIME DOWNLOAD LINK (FAST SPEED) MA hope o ka uku

* Ke Kulanui ʻAmelika o Cardiology 2021 Congress *

ACC.21, ʻO ka All Virtual Experience, e hōʻike i ka noiʻi lapaʻau a me ka hoʻonaʻauao ma waena o nā ala aʻo 11 i loko o kahi hālāwai kūkā a me ka hoʻolako ʻana i nā mea hou e hoʻololi i ka hana ma ka mālama.

E komo i loko o nā papa he 200 oi aku ma nā ala aʻo he 11 e hōʻike ana i ka ʻepekema hope loa, ka noiʻi hoʻololi hoʻomaʻamaʻa a me ka hoʻonaʻauao ʻokiʻoki āu i manaʻo ai mai ke kau ʻepekema makahiki o ke Kulanui.

E ʻimi i ka Expo a e aʻo hou aʻe e pili ana i nā holomua hou i nā lāʻau lapaʻau, kiʻi kiʻi, nā mea hana, IT olakino a me nā lawelawe āu e pono ai e hoʻolako i ka mālama kiʻekiʻe no kāu mau maʻi. E kamaʻilio me nā mea hōʻikeʻike komo e pane i kāu mau nīnau.

E hui pū me mākou no ka 70^th Hōʻuluʻulu makahiki ʻoiai mākou e hoʻomaikaʻi aku i nā mea lanakila 2021 a me kā lākou hāʻawi ʻana i ka ACC a me ka ʻoihana, e hoʻokipa i nā Fellows a me nā hoa hou, a e ʻike i ka pelekikena hou o ACC ʻo Dipti Itchhaporia, MD, FACC.

Mai Mei 15 - 17, ACC.21 kahe ʻia i nā tausani o nā lālā o ka hui cardiovascular mai nā wahi a puni o ka honua! E hoʻokaʻawale i ka manawa e makaʻala i ka hoʻonaʻauao ʻana a pau mai ACC.21 me ke komo ʻana ma On Demand. Nānā 300+ mau kau e hōʻike ana i ka noiʻi hoʻololi hoʻomaʻamaʻa a me ka hoʻonaʻauao ʻokiʻoki. Eia kekahi, mai poina i ka ʻoi aku o 3,3000 eAbstracts, 100+ mea hōʻikeʻike, a me ka manawa e hoʻolauleʻa ai i nā hoʻokō o kā mākou mau hoa hana me Convocation. He laʻana mai kahi ʻano hoʻonaʻauao like ʻole ke kūpono iā ʻoe - mai kou home, keʻena, a i ʻole ka hele ʻana - ma nā ala aʻo he 11. E haʻalele ʻo ACC.21 iā ʻoe i kēia lā no ka noiʻi lāʻau lapaʻau hou loa a e ʻike ʻoe i ka hopena o ka mālama ʻana i kāu mau maʻi.

 ʻO ACC ka hālāwai kūkā makahiki o ka American Automatic Control Council (AACC), ka hui lālā o ka US no ka International Federation for Automatic Control (IFAC). ʻO nā kākoʻo kākoʻo o ka ACC me ka American Institute of Aeronautics and Astronautics (AIAA), American Institute of Chemical Engineers (AIChE), American Society of Civil Engineers (ASCE), American Society of Mechanical Engineers (ASME), IEEE Control. Pūnaehana Pūnaehana (IEEE-CSS), Institute for Operations Research and the Management Sciences (INFORMS), International Society of Automation (ISA), Society for Modeling & Simulation International (SCS), a me Society for Industrial & Applied Mathematics (SIAM).

*Nā mea: (297 wikiō)

|   406 Hui Pū ʻAmelika Hui Pū ʻIa o Cardiology Journal of the American Medical Association Late-Breaking Clinical Trials.ts

| 407 Hui Pū ʻAmelika Hui Pū ʻIa o CardiologyNew England Journal of Medicine Late-Breaking Clinical Trials.ts

| 411 Nā hoʻāʻo hoʻāʻo hoʻāʻo ʻana i ka hope V.ts

| 908 Hoʻohanohano ʻia i ka ʻimi noiʻi ʻana i nā kiʻi multimodality a me ka makahiki ma Review.ts

| 910 Highlighted Original Research Ischemic Heart Disease and the Year in Review.ts

| He ʻike i kēia manawa no ka ʻike ʻana a me ka hoʻokele ʻana o ka haʻahaʻa haʻahaʻa haʻahaʻa haʻahaʻa haʻahaʻa haʻahaʻa.ts Severe Aortic Stenosis.ts

| He ipu hoohehee o na ma'i ma'i ma'i valvular ma'i 'a'ohe puke kuke, aka he mau noi ma'amau mai ka Valve Guidelines.ts

| ʻO kahi ala kūpono i ka hoʻoholo like ʻana i ka wā e mālama ai i ka maʻi puʻuwai puʻuwai.ts

| He Manaʻo o ka RADIANCE-HTN Global Clinical Trial Program A nānā i ka TRIO cohort.ts

| ACC Cardiology Hour.ts

| ACC.21 Nā mea koʻikoʻi i ka hypertension.ts

| ACC21-Nīnau-Nīnau pinepine-UPLOADED-Mei-11-2021.pdf

| ʻO ka hoʻololi ʻana i nā mea e pono ai nā FIT e ʻike no ka hoʻomaka ʻana i kahi ʻoihana olakino a kūleʻa.ts

| Na Ma'i Puuwai Hapu makua i hoohuoi ia'u.ts

| ʻO nā noi no ka Nuclear Cardiology Advanced ma 2021.ts

| Nā holomua a me nā haʻawina hou no ka mālama ʻana iā MR me ka hoʻoponopono a me ka hoʻoponopono hou ʻana o Abbott.ts.

| Hoʻonui i ka mālama ʻana i ka maʻi ma waena o ka puʻuwai hoʻomau.ts

| Hoʻonui i nā ʻōnaehana o ka mālama ʻana ma STEMI, Stroke, Cardiac Arrest, Shock.ts

| Anticoagulation Trivia mai ka A a i ka V Management Strategies ma ka ʻaoʻao o ka Papa Meeting on Demand.mp4

| Nā Hoʻopaʻapaʻa Antithrombotic ma ka Cath Lab.ts

| Hoʻoponopono Antithrombotic i nā poʻe maʻi me ka Atrial Fibrillation i ka PCI.ts

| ʻO nā hoʻopiʻi aortic valve nā pilikia kino.ts

| Hoʻonui i nā hōʻailona aortic valve.ts

| Ka hoʻohana ʻana o Dual Source CT i ke kiʻi ʻana i ka naʻau - ka nānā ʻana i ka Structural Heart Disease.ts

| Ke noi ʻana i nā alakaʻi no ka hoʻokele lipid ma nā poʻe kūikawā.ts

| ʻO Arrhythmogenic Cardiomyopathies e haʻi mai iaʻu i kaʻu mea e pono ai e ʻike.ts

| ASCVD Risk Factors and Beyond.ts

| ʻO ka hoʻokele fibrillation atrial ma Athletes.ts

| ʻOi aku ka maikaʻi o JACC Journals & Eugene Braunwald Keynote.ts

| ʻO nā hana maikaʻi loa o nā kiʻi multimodality ma Percutaneous Mitral Interventions.ts

| Ma waho aʻe o kahi Puʻuwai Haʻihaʻi Multisystem Ke kaumaha ma ka hATTR Amyloidosis.ts

| Ma waho aʻe o Atrial Fibrillation - Atrial Cardiopathy ma ke kumu o Cryptogenic Stroke.ts

| Nā Kūlana Hoʻoemi koko Ma hope o PCI.ts

| Breakthrough Transcatheter Pulmonary Valve Koho Lapaʻau no nā mākua a me nā keiki CHD maʻi.ts

| Cardiac CT ma Clinical Practice.ts

| ʻO ka moʻomeheu cardiac Medium nā manaʻo o kēia manawa i ka Infective Endocarditis.ts

| ʻO ke kiʻi kiʻi puʻuwai i nā poʻe ʻelemakule i hoʻohana nui ʻia a i ʻole ka hoʻohana ʻole ʻia ʻana o nā wahi hana no nā Clinicians.ts

| ʻO ke kani ʻana o ka naʻau o ka mālama ʻana i ka Ultrasound a puni ka honua.ts

| Ka Neʻe ʻana o ka Puʻuwai i ka Improve.ts

| Cardio-Oncology i keia la.ts

| ʻO ka holomua o ka puʻi maʻi maʻi puʻuwai, nā Paradigms a me nā pilikia i hoʻoholo ʻole ʻia.ts

| Nā Puʻupuʻu Puʻuwai Cardiogenic a me nā mea hana no ka Cardiogenic Shock.ts

| ʻO ka Cardiologist Versus Calcium Unstoppable Force Hui me nā mea hiki ʻole ke hoʻoneʻe ʻia.ts

| Noʻonoʻo Cardiovascular ma Amateur a me nā ʻAlepa ʻOihana.ts

| ʻO ke kiʻi kiʻi puʻuwai no ka hōʻoia ʻana a me ka mālama ʻana i ka maʻi coronary microvascular.ts

| ʻO ke kiʻi puʻuwai puʻuwai e hoʻonui ai i ka Prevention.ts

| Ka mālama ʻana i ka mea maʻi me STEMI ma 2021.ts

| Ke aʻo ʻana i ka hihia no ka hui Cardiovascular.ts

| Nā hihia mai nā alakaʻi no nā Clinicians.ts

| ʻO ka CCM® Therapy - He ala e pili ana i nā mea hana no ka mālama ʻana i ka pau ʻole o ka naʻau.ts

| ʻO nā pilikia o ka hoʻololi ʻana i nā maʻi maʻi i ka hānau ʻana.

| Nā hihia paʻakikī ma Cardio-Oncology.ts

| ʻO ka loiloi ʻana i ka ʻeha o ka umauma ma 2021 pilikia like, nā mea hana hou, nā nīnau hou.ts

| Maikaʻi mai ka huikau i loko o ka naʻau hāʻule me ka Preserved Ejection Fraction (HFpEF).ts

| Ke noiʻi ʻana i nā hoʻokolohua lapaʻau e hoʻonui i kāu pāʻani.ts

| ʻO nā ho'āʻo hoʻokolohua ʻo ThunderDome ka mea e hoʻonani ʻia i nā mea ʻoi loa

| Paʻakikī a Kiʻekiʻe ʻo PCI Case Based Joint Symposium.ts

| Ka Hoʻoholo Hoʻoholo ʻana i ka hihia paʻakikī – ʻO ka hui puʻuwai i ka hana He hui hui ʻia e TCT.ts

| ʻO nā pilikia pilikia ma ka maʻi puʻuwai Valvular.ts

| ʻO ka hoʻoponopono ʻana i ka maʻi aortic valve i kēia manawa.ts

| Nā Paʻakikī o kēia manawa i ka Structure Care Critical Care Cardiac, Staffing, Training and Beyond.ts

| Nā kumuhana hoʻopaʻapaʻa ma ka hoʻololi ʻana i ka naʻau a me nā mea kōkua Ventricular.ts

| Nā hoʻopaʻapaʻa ma Arrhythmia Therapy.ts

| Nā hoʻopaʻapaʻa i ka hoʻoponopono ʻana a me ka hoʻoponopono ʻana i ka maʻi naʻau hānau.ts

| Nā hoʻopaʻapaʻa ma ka ICU Management of Congenital Heart Disease.ts

| ʻO ka ʻike kumu i ka hana pono o ka Stable Ischemic Heart Disease.ts

| Ka ʻike kumu i ka hana e hoʻi i nā kumu o Aortic Stenosis.ts

| ʻO ka ʻike kumu i ka hana ʻo ke alakaʻi hope loa i lipids.ts

| ʻO ka ʻike kumu i ka hana ka mea e pono ai nā kānaka a pau e ʻike e pili ana iā HFpEF.ts

| ʻO ka maʻi ʻaʻaʻa ʻaʻa - Atherogenesis, Acute Coronary Syndromes a Stroke.ts

| ʻO Coronary IVL ʻO wai, he aha, ma hea, i ka manawa a me ke kumu he alakaʻi alakaʻi no ka hoʻomaʻamaʻa kino.ts

| ʻO COVID 19 a me nā haʻawina i aʻo ʻia a me nā kuhikuhi i ka wā e hiki mai ana.ts

| COVID-19 a me ka Echocardiography - Ka hopena, ke kiʻi, a me ka Innovation.ts

| ʻO nā pilikia koʻikoʻi ma nā maʻi maʻi maʻi maʻi.ts

| ʻO nā ala i kēia manawa i ka Antiplatelet Therapy no PCI ma Acute Coronary Syndrome.ts

| Nā hoʻopaʻapaʻa a me nā hoʻopaʻapaʻa i kēia manawa ma CAD Imaging.ts

| Kāohi CVD i ka Post-COVID19 Era2.ts

| Nā hoʻopaʻapaʻa ma ka hoʻoponopono ʻana i ka arrhythmia i ka maʻi naʻau Congenital.ts

| Pono mākou e hoʻopaʻapaʻa i ka Antiplatelet Therapy no PCI.ts

| Hoʻopaʻapaʻa hoʻopaʻapaʻa ma STEMI Care.ts

| Luu Hohonu I.ts

| Luu Hohonu II.ts

| Hoʻoholo ʻia e hāʻule Pehea e pale ai i ka naʻau.ts

| ʻO ka Diabesity He Moʻolelo no ka ʻObesity, Inflammation and Cardiometabolic Risk.ts

| Ka ma'i ma'i a me ka na'au.ts

| ʻO ka hoʻāʻo ʻana i ka maʻi maʻi maʻi maʻi ischemic e koho ana me ka naʻauao.ts

| ʻO nā ʻokoʻa a me ke kuleana o nā mea e hoʻoholo ai i ke ola kino ma ka maʻi maʻi ischemic a me ka paʻa.ts

| Hoʻokaʻawale i nā Kūkākūkā ʻikepili e pili ana i ka hoʻokele ʻana o SCAD.ts

| Na Alanui Puuwai I ka ma'i ma'i.ts

| Drug Jeopardy Pharmacological Conundrums ma Arrhythmia Management.ts

| Nā ECG Me ka Poʻe Hoʻonaʻauao Hoʻomaʻamaʻa Noʻonoʻo No ka Cardiovascular Clinician.ts

| Nā Maʻi Uila - Nā Maʻi ʻAiʻoniʻoni a me ka Hoʻokele.ts

| Nā ʻenehana hou aʻe i loko o ka maʻi Vascular.ts

| Nā Kuleana Pono Endovascular i Bailout Techniques.ts

| Nā pilikia EP i nā poʻe maʻi maʻi maʻi maʻi maʻi - ma waho o ka naʻau.ts

| Nā Momi Vascular Pono no ka Cardiovascular Clinician.ts

| Nā mea nui o ka hoʻokele fibrillation atrial - E aʻo mai nā Experts.ts

| Hoʻololi ʻia o ka hoʻololi ʻana o ka ʻūhā Aortic i nā maʻi haʻahaʻa.ts

| Hoʻonui i nā Frontiers ma Vascular Intervention.ts

| Hoʻonui i ka Toolkit Tackling Residual Atherogenic Lipid Risk.ts

| Ke ʻimi nei i nā Synergies Hou e hoʻohui ana i kahi Cardiac CT Scanner a me Interventional C-lima i kā mākou Cath Lab.ts

| ʻIke ʻia ʻo I.ts

| ʻImi ʻImi Kaulike II.ts

| ʻImi ʻImi Kaulike III.ts

| Fellows Bootcamp Coronary and Peripheral Disease Management - ʻO nā hihia maikaʻi loa āu i ʻike ai iā Yet.ts

| Nā hoa Bootcamp Structural.ts

| FIT Forum Stump the Professor.ts

| FIT Jeopardy Battle of the State Chapters Finals.ts

| Kakau i ka Interventional Complications.ts

| ʻEhā mau hiʻohiʻona o ka maʻi Myocardial a me ka naʻau hāʻule - Myocarditis, HFrEF, HFpEF, HCM.ts

| Mai ka hoʻopaʻapaʻa a hiki i ka akaka i ka Weight Loss Therapies.ts

| Hoʻopili kiʻi no ka transcatheter edge-to-edge mitral valve repair.ts

| Ka Malama Kaulike o na Ma'i me Acute Coronary Syndrome.ts

| Genetics ma o Geriatrics - Kāohi CV ma o ka Lifespan.ts

| Loaʻa i ke kumu o nā hopena ʻai.ts

| Hoʻihoʻi i kou ola a me kou ʻano ma CVD.ts

| Ke kaumaha o ke ao holoʻokoʻa o ka maʻi cardiovascular i nā wāhine.ts

| Ke alakaʻi honua a me ka hoʻonaʻauao ʻoihana i ka COVID-19 Era.ts

| Nā Kūkākūkā Nui ma ka Lapaʻau Vascular.ts

| Hoʻohana i ka mana o ka ʻenehana ka nānā ʻana a me ka hoʻokele mamao ma HF.ts

| Kōkua LDL.ts

| E kōkua i kāu mau maʻi MI hou loa e loaʻa i ka LDL-C haʻahaʻa a hoʻemi i ka pilikia o kekahi MI (2).ts

| E kōkua i kāu mau maʻi MI hou loa e loaʻa i ka LDL-C haʻahaʻa a hoʻemi i ka pilikia o kekahi MI.ts

| Hemodynamics of Heart Failure You thought you know them.ts

| Heterotaxy Syndrome a i ʻole Somerism nona ka ʻaoʻao

| Hōʻike ʻia i ka Electrophysiology Noʻonoʻo Kumu a me ka Makahiki ma Review.ts

| Hōʻike ʻia i ka ʻimi noiʻi kumu ʻole o ka naʻau a me ka Cardiomyopathies a me ka makahiki ma Review.ts

| Hoʻohanohano ʻia ka ʻimi noiʻi kumu a me ka hoʻolālā a me ka makahiki ma Review.ts

| Hoʻohanohano ʻia i ka ʻimi noiʻi kumu ʻo Pediatric and Congenital Heart Disease and the Year in Review.ts

| Hoʻohanohano ʻia ʻo Kāohi Noʻonoʻo Kumu a me ka Hoʻolaha Ola a me ka makahiki ma Review.ts

| ʻO ka maʻi maʻi pulmonary vascular maʻi a me ka makahiki ma Review.ts

| ʻIke ʻia i ka ʻimi noiʻi kumu ʻo Valvular Heart Disease and the Year in Review.ts

| ʻIke ʻia i ka ʻimi noiʻi kumu lāʻau lapaʻau Vascular a me ka makahiki ma Review.ts

| Estrogen hemolele! ʻO nā ʻokoʻa o ka wahine i loko o ka naʻau hoʻomaʻamaʻa ʻole Biology, Bias a i ʻole ʻelua.ts

| Pehea e hiki ai iaʻu ke haʻi aku inā e hana maʻamau ana kēia hoʻololi ʻana o ka Aortic Valve.ts

| Pehea e komo ai ka Paradise Renal Denervation i loko o ka Management Treatment Treatment.ts

| ʻEhia ka nui o ka hoʻokele ʻana i nā lāʻau lapaʻau ʻoi loa e ka lāʻau Deprescribing.ts

| Pehea e lilo ai i Mentor & Mentee.ts

| Pehea e lilo ai i mea noiʻi holomua ma kēlā me kēia pae o kāu hana.ts

| Pehea e koho ai a hoʻonui i ka pacing i nā poʻe maʻi me ka puʻuwai hoʻokele hoʻokele ʻōnaehana Pacing a me CRT.ts

| Pehea e hana ai i nā hihia i hele mai ka pilikia ʻole a i ka moeʻuhane.ts

| Pehea e hoʻopaʻa ai i kahi LM e like me ka haku haʻalele i ka papa hana PCI nui.ts

| ʻOkoʻa nā alakaʻi no ka hypertension ma nā wahi a puni o ka honua e like me ka nui o koʻu paʻi koko i kēia lā .ts

| Hooponopono i ka ma'i ma'i ki'i He hiki mai piha i na olelo hoopomaikai.ts

| ʻIke wau i ka hōʻike no laila pehea wau e hoʻohui ai i ka meaʻai a me ke ʻano o ka nohona ma kaʻu Clinic.ts

| ʻO ka noʻonoʻo nā mea hou a pau i ka Cath Lab.ts

| Kiʻi Kiʻi Cardiomyopathies Nā hihia hoʻokūkū.ts

| Ka Hoʻoholo Kiʻi ʻana i ka hoʻomaʻamaʻa lāʻau lapaʻau i kēlā me kēia lā no ka maʻi coronary artery.ts

| Ke Kiʻi ʻana o ka maʻi puʻuwai hānau ʻike i nā mea a mākou i ʻike ʻole ai ma mua.ts

| Ke hoʻokō nei i nā alakaʻi alakaʻi hoʻomalu i ka Atrial Fibrillation The Good, The Bad, and The Ugly.ts

| Nā pilikia a me nā hiʻohiʻona o nā maʻi maʻi Valvular Indirect.ts

| ʻO nā meaʻai meaʻai hou a me nā meaʻai no ka maʻi Cardiometabolic.ts

| ʻIke o ka maʻi BAV mai Asia a me Western Perspectives.ts

| Nā Pūnaehana Kūikawā Nui o kēia lā no ka lā ʻapōpō i hoʻomaikaʻi ʻia.ts

| Nā hihia hoʻokūkū hoʻokūkū II He Potpourri Interventional & SHD ʻAʻole i Miss.ts

| ʻO nā hihia hoʻokūkū hoʻokūkū e hana iā ʻoe e noʻonoʻo.ts

| Invasive Imaging and Physiology Diagnosis and Management of ACS Patients and Plaques.ts

| Ke emi nei ka maikaʻi o ka noiʻi maʻi cardiovascular i ka mea e hoʻomau ai ka noiʻi.ts

| ʻO Jardiance® (empagliflozin) papa ʻO ka hopena o ka EMPA-REG OUTCOME.ts

| ʻO Jeopardy.ts

| Ka Huakai o ka Ventricle Akau i ka Pulmonary Hypertension.ts

| Kick E hoʻomaka i kāu noiʻi Career.ts

| Nā hoʻāʻo hoʻāʻo hoʻāʻo ʻana i ka hope IV.ts

| Nā hoʻāʻo hoʻāʻo hoʻāʻo ʻana i ka hope.ts

| Ka Hoʻomaka ʻana i kahi ʻoihana kūleʻa ma ka cardiology academic mau mea nui i ka Success.ts

| Left Atrial Appendage Occlusion Clinical Challenges.ts

| ʻO ka haʻihaʻi hoʻokuke ventricular hema i hala, i kēia manawa, a me ka wā e hiki mai ana i ka mālama ʻana i ka naʻau.ts

| E kiʻi kākou i ke kino! Hooikaika kino a me ke ola kino.ts

| ʻO ka hopena o ke ola o nā mea pilikia o ka maʻi cardiovascular i nā maʻi me ka maʻi puʻuwai hānau.ts

| Noho ma 3D.ts

| ʻO nā pilikia maʻi maʻi PAD, nā ʻokoʻa, a me nā hopena i hoʻokumu ʻia i ka maʻi.ts

| Ka mālama ʻana i ka Cardiology Pediatric a me ka ʻoki ʻana i ka naʻau ma ka Post-COVID World.ts

| Ka mālama ʻana i ka mea maʻi ma 2021 Mai Cybersecurity, i MRI a me Beyond.ts

| Ka Hooponopono ana i ka ma'i ho'olele pu'uwai o keia la.ts

| ʻO nā kāne mai Mars mai, ʻo nā wahine mai Venus nā mea pilikia e hoʻonui ai i ka pilikia CVD.

| ʻO nā lāʻau lapaʻau liʻiliʻi a me nā mea hana ma AHF e hōʻike ana i ka 2021.ts

| MINOCA He Hōʻike a haʻi pū me ka poʻe loea.ts

| ʻO ka maʻi ʻo Mitral Valve a me ka Puʻuwai Hoʻopaʻa ʻia i ka mea i hala ʻole a hewa paha e like me ka uku ʻia.ts

| Hoʻoponopono ʻo Mitral Valve Percutaneous Mitral Valve Repair.ts

| Nānā ECG Mobile Pehea e hiki ai iā mākou ke hoʻohana i ka Wearable Data.ts

| Multimodality Cardiac Imaging and Modern Media.ts

| Nā Kiʻi Multimodality ma Cardio-Oncology.ts

| Nā Kiʻi Multimodality i nā hihia paʻakikī o ka Endocarditis Infective.ts

| Multimodality Imaging of Athletes He aha ka ʻōlelo aʻoaʻo hou iā mākou.ts

| Pono e ʻike i nā ʻōlelo aʻoaʻo no ka hoʻopuka ʻana ma JACC Journals.ts

| ʻO ka Myocarditis a me ka Puʻuwai hāʻule.ts

| Nā alakaʻi alakaʻi hou AHAACC Valve A Paradigm Shift in Management of Severe Aortic Stenosis.ts

| ʻO nā lāʻau lapaʻau hou a e kū mai ana no HFrEF! He aha kā mākou e hana ai.ts

| ʻO nā lāʻau lapaʻau hou i ka poʻe ʻĀsia.ts

| Nā Hana Hou i loko o ka Cardiovascular Imaging e hoʻokomo ana i ka naʻauao artificial i loko o ka hana o kēlā me kēia lā.ts

| Nā Manaʻo Hou no ka nānā ʻana i nā maʻi ma hope o TAVRSAVR.ts

| Na Nuts & Bolts o ka hapai a me ka ma'i puuwai.ts

| Obstructive Sleep Apnea a me Cardiovascular Outcomes He aha nā mea e pono ai ka poʻe Cardiologists e ʻike.ts

| ʻO nā kumuhana Off-Beat i ka Puʻuwai ʻaʻole e hoʻomaikaʻi i ka hana ʻino ma o ka mālama ʻana i ka Rhythm.ts

| ʻO ka hoʻonui ʻana i ka hoʻokele LDL-C i nā poʻe maʻi MI i kēia manawa.

| ʻO ka hoʻonui ʻana i ke ala mālama maʻi a me ka hoʻokele LDL-C i nā maʻi me MI.ts hou loa

| Ke lanakila 'ana i ka Therapeutic Inertia Maximizing Guideline Driven Medical Therapy in Heart Failure.ts

| Nā Mākaʻikaʻi Antithrombotic Mākua no ACS a me PCI.ts

| PCI i nā maʻi me CKD Insights mai kahi nephrology a me interventional cardiology partnership.ts

| Perlas practicas en manejo de lipidos.ts

| Nā Manaʻo no ka Pulmonary Hypertension.ts

| Pharmacologic and Lifestyle Management for ISHD No ke aha nā ʻokoʻa i ka Care Matter.ts

| Pharmacology I Hoonui i ka Cardiovascular Pharmacology Toolbox.ts

| ʻO Pharmacology II Ka Hoʻoponopono ʻana i ka Epidemic Supersized o Cardio-diabetes.ts

| ʻO Pharmacology III ʻO kahi auneke o ka pale ʻana he mea kūpono ia i kahi paona o ka lāʻau lapaʻau - nā holomua ma Cardio-Oncology.ts

| Nā Manaʻo Pharmacotherapy ma Cardio-Obstetrics.ts

| ʻO nā Parlays Polite i ka Pulmonary Hypertension.ts

| Nā Mechanism Hiki ke kuleana no ka hopena o nā Incretins ma Atherosclerosis.ts

| Nā Momi Maʻamau ma ASCVD a me Lipid Management.ts

| ʻO ka mālama mua ʻana no ka ʻoki ʻana i ka naʻau ʻole nā ​​hoʻolālā e puka mai ana a me nā hoʻopaʻapaʻa mau.ts

| ʻAʻole i kūpono i nā mea a pau ka pololei o ka hoʻokaʻawale ʻana a me ka mālama ʻana i ka hemahema o ka naʻau

| ʻO PCI pololei ma ke ao maoli He aha kaʻu e hoʻohana ai i kēlā me kēia lā.ts

| ʻO ka Proarrhythmia Nānā i waho! Mai ka ICU a i ka meaʻai a mākou e ʻai ai.ts

| ʻO ka holomua ʻoihana ma waena o ke aʻo aʻoaʻo Cardiology Life Course.ts

| ʻO ka ʻoihana a me nā loina ma Cardiology.ts

| ʻO ka holomua o ka Pulmonary Arterial Hypertension Pharmacotherapy i pāʻani ʻia i loko o kahi hihia maʻi.ts

| Mālama ʻia ka ʻike ʻana a me ka mālama ʻana i ka maʻi coronary kiʻekiʻe a me ka paʻakikī o ka PCI no nā hopena lōʻihi.ts

| Pulmonary Hypertension Primer WHO ʻO nā Pūʻulu.ts

| Ke hoʻokiʻekiʻe ʻana i ka manaʻo kānalua no ka Hypertrophic Cardiomyopathy.ts

| Kau ahi wikiwiki no ka ma'i puuwai.ts

| Noʻonoʻo hou i ka 90-Day High-Risk Period Post-AMI Kūkākūkā Kūkākūkā e pili ana i ka Cholesterol Efflux a me ApoA-I ma Plaque Stabilization.ts

| Nā hoʻāʻo hou ma SIHD Unuhi i nā hopena i loko o Clinical Practice.ts

| Kakau inoa ma Cardiac Imaging Pehea lākou e hoʻololi ai i ka Clinical Practice.ts

| ʻAʻole hoʻoponopono ʻia ka hoʻoponopono ʻana no ka manawa lōʻihi ka hahai ʻana o ka ʻoki ʻana no ka maʻi puʻuwai hānau.ts

| E Hoʻi E Paʻani i ka Mea a ka Poʻe akamai e hana ai.ts

| Nā Cardiomyopathies hiki ke hoʻihoʻi ʻia ʻo Arrhythmias, Pacing, Dyssynchrony and Inflammation.ts

| ʻAʻohe ʻaoʻao ʻākau.ts

| ʻO ke kuleana o ka Multimodality Imaging i ka ʻike a me ka mālama ʻana i nā hoʻopiʻi cardiovascular i nā maʻi me COVID-19.ts

| Nā ʻokoʻa wahine ma Arrhythmias.ts

| Nā Hui Pūʻali a me nā Docs Shock.ts

| No laila makemake ʻoe e lilo i poʻokela o Cardiology.ts

| Star Wars He aha ka wā e hiki mai ana no EP.ts

| ʻO nā kūlana paʻa no ka Revascularization ma SIHD i ka wā i kaupalena ʻia ai nā hōʻike akā nui nā manaʻo.

| Nā Hoʻolālā no ka ʻAlo ʻana i ke koko ma hope o PCI.ts paʻakikī

| ʻO ka hoʻomaʻamaʻa ʻana i ka maʻi a me ka mālama ʻana i ka maʻi ʻaʻaʻa coronary.ts

| ʻO ke koʻikoʻi echo ma waho aʻe o CAD.ts

| Hoʻopaʻa ʻana i ka maʻi ʻaʻai ʻana i ka poʻe i mālama ʻole ʻia.ts

| Nā Hoʻopiʻi Kūleʻa & Pehea e Hana ai iā lākou.ts

| Nā pilikia o ka maʻi puʻuwai i ka makahiki 2021 - nā maʻi aortic, mitral a me tricuspid, hypertrophic cardiomyopathies.ts

| Ka Ho'opa'a 'ana i ka Poino Cardiometabolic He Kūkākūkā Ma muli o ka hihia.ts

| ʻO ka Advanced Heart Failure Therapies o LVAD a Transplant Who, What, When, Where, Why, and How DISCUSSION.ts

| ʻO ka Advanced Heart Failure Therapies o LVAD a me Transplant Who, What, When, Where, No ke aha, and HowDIAPOSITIVAS.ts

| ʻO ka hoʻopaʻapaʻa mau ʻo TAVR Versus SAVR – ʻAʻole kūpono ka nui hoʻokahi i nā mea āpau.ts

| ʻO ka makahiki o ka European Heart Journal ma Cardiovascular Medicine.ts

| ʻO ka Evolving Lipids Landscape i kēia manawa a me nā hui nonstatins e puka mai nei ma ke koi 1.mp4

| ʻO ka Evolving Lipids Landscape i kēia manawa a me nā hui nonstatins e puka mai nei ma ke koi 2.mp4

| ʻO ka Evolving Lipids Landscape i kēia manawa a me nā hui nonstatins e puka mai nei ma ke koi 4.mp4

| ʻO ka Evolving Lipids Landscape i kēia manawa a me nā hui nonstatins e puka mai nei ma ke koi 5.mp4

| ʻO ka Evolving Lipids Landscape i kēia manawa a me nā hui nonstatins e puka mai nei ma Demand3.mp4

| ʻO ka wā e hiki mai ana o Dyslipidemia Management.ts

| ʻO nā pilikia a me nā manawa kūpono o ka hui TeleHealth Cardiac.ts

| Ua hiki mai ka manawa no ka nānā pono ʻana no ka Asymptomatic Atrial Fibrillation.ts

| ʻO ka ʻae ʻana o US-China no ka PVI ʻoi loa ka hoʻohana ʻana i ka RF Energy i nā poʻe maʻi me Paroxysmal AF a me AF Workflow Sharing.ts

| Thrombosis & Kāohi ʻana ma COVID-19 He aha kā mākou e nalo nei.ts

| E hoopololei i ka hewa iloko o ka naau poino.ts

| ʻO nā hōʻailona kiʻekiʻe no ka Cardiovascular Magnetic Resonance i ka Modern Cardiology.ts

| Kumuhana kumuhana i ka Pulmonary Arterial Hypertension.ts

| ʻO nā hihia koho paʻakikī ma Cardiogenic Shock.ts

| Ke nānā nei i ka hopena CV o SGLT2i Practice Essentials Meeting on Demand 1.mp4

| Ke nānā nei i ka hopena CV o SGLT2i Practice Essentials Meeting on Demand 2.mp4

| Ke nānā nei i ka hopena CV o SGLT2i Practice Essentials Meeting on Demand 3.mp4

| Ke nānā nei i ka hopena CV o SGLT2i Practice Essentials Meeting on Demand 4.mp4

| Transcatheter Mitral Valve Hoʻololi Hoʻonui i nā hōʻailona a me ka hoʻāʻo Update.ts

| Anatomy naʻau unuhi unuhi.ts

| Treat the Pump or Treat the Rhythm E kamaʻilio kākou no ʻelua.ts

| Hoʻomaʻamaʻa i nā maʻi like ʻole e mālama i ka naʻau ʻaʻole moe, hoʻoikaika kino, hoʻemi kaumaha, hao a me nā mea hou aʻe.ts

| ʻAʻole hou ʻo Tricuspid Regurgitation Ka Valve Poina.ts

| Ma lalo o nā hoʻopaʻapaʻa kukui kukui ma Interventional Cardiology.ts

| Ka hoʻomaopopo ʻana i ka hopena o Lp(a) ma ASCVD Ke nānā aku nei i ka pilikia CV hou, nā alakaʻi, a me ka testing.ts

| Ke wehe nei i na mea pohihihi o ka cardiac Amyloidosis.ts

| ʻElua Pepa Lapaʻau a me kahi Kiko Paahana.ts

| Ka wehewehe ʻana o ka naʻau.ts

| Nā mea hou i ka mālama ʻana i ka Hypertrophic Cardiomyopathy.ts

| Ka hoʻohana ʻana i nā Anticoagulants waha pololei i nā hoʻolālā dosing paʻakikī a me nā maʻi paʻakikī.ts

| ʻO Valvular Conundrums Grey Area Cases, Ka Manaʻo o ka poʻe loea.ts

| VASCEPA® (icosapent ethyl) Hoʻokiʻekiʻe i ke kūlana o ka mālama.ts

| Nā hōʻike ʻana o ka maʻi maʻi o COVID-19 a puni ka honua.ts

| Nā Haʻawina Vasculo-Oncology i aʻo ʻia no ka hoʻomaʻamaʻa lapaʻau ma 2021.ts

| Nā Kūlana Venous 2021.ts

| ʻO Venous Thromboembolism Nā Hoʻopaʻapaʻa i kēia manawa a me ka Hoʻokele Practical.ts

| ʻO ka ʻike maʻi maʻi ma waho no ka poʻe Electrophysiologists Cardiac High Yield Topics.ts

| Hoʻopili i nā Plaques Vulnerable a i ʻole Pharmacologic Therapy.ts

| Kiai Hoouna.ts

| He aha kā mākou e aʻo ai mai kekahi i kekahi no ka mālama ʻole ʻana o ka naʻau honua.ts

| ʻO ka mea āu i ʻike ʻole ʻaʻole hiki ke kōkua iā lākou – Hoʻokele mamao o nā maʻi me ka hoʻohana ʻana i nā Wearables.ts

| He aha ka mea i loko o ka inoa Nā hana hoʻomaʻamaʻa o ka 4th Universal Definition of MI.ts

| He aha ka mea hou ma ka HF Pharmacotherapies ʻO ka Hui He aha, Pehea, a me Wow ma ke koi 1.mp4

| He aha ka mea hou ma ka HF Pharmacotherapies ʻO ka Hui He aha, Pehea, a me Wow ma ke koi 2.mp4

| He aha ka mea hou ma ka HF Pharmacotherapies ʻO ka Hui He aha, Pehea, a me Wow ma ke koi 3.mp4

| He aha ka mea hou ma ka HF Pharmacotherapies ʻO ka Hui He aha, Pehea, a me Wow ma ke koi 4.mp4

| He aha ka mea hou ma ka HF Pharmacotherapies ʻO ka Hui He aha, Pehea, a me Wow ma ke koi 5.mp4

| Ke lanakila ka momona i ka ʻiʻo obesity a me ka HFpEF Epidemic.ts

| Ke hana pū nei e hoʻomaikaʻi i ka mālama ʻana i ka maʻi maʻi keiki a me ka naʻau hānau a puni ka honua 5.ts

| ʻO ka World Heart Federation i hōʻike ʻia i ka noiʻi me ka makahiki ma Review.ts

| ʻAe, ʻAʻole, Pehea paha e ʻike ai a mālama i ka INOCA (Ischemia a ʻaʻohe Obstructive Coronary Artery Disease) i kēia lā.ts

| ʻO kāu PVI Toolkit.ts